C. Guo

Glucocorticoid replacement therapy: are patients over treated and does it matter?

R. Eastell, A. Weetman, S. Peacey, 1997, Clinical endocrinology.

Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study

S. Atkinson, R. Barr, J. Wiernikowski, 2005, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Mechanisms of bone loss after cardiac transplantation.

R. Eastell, C. Guo, T. Locke, 1998, Bone.

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.

R. Eastell, R. Coleman, O. Purohit, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1211 Randomised double-blind comparison of pamidronate or clodronate for hypercalcaemia of malignancy: Effects on bone metabolism markers

R. Eastell, R. Coleman, O. Purohit, 1995 .

Metabolic effects of pamidronate in patients with metastatic bone disease.

R. Eastell, R. Coleman, O. Purohit, 1996, British Journal of Cancer.

Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia

R. Eastell, A. Weetman, C. Guo, 1996, Clinical endocrinology.

Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.

R. Eastell, T. Jones, C. Guo, 1997, The Journal of clinical endocrinology and metabolism.

Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism.

R. Eastell, B. Harrison, R. Hannon, 2000, European journal of endocrinology.

Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.

R. Eastell, A. Assiri, C. Guo, 1996, The Journal of clinical endocrinology and metabolism.